(SYRS) Syros Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Syros Pharmaceuticals | (SYRS) share price targets
Complete technical analysis of Syros Pharmaceuticals (SYRS) by charts plus indicators, forecast predictions and share price targets for Syros Pharmaceuticals (SYRS)
Syros Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Syros Pharmaceuticals is 280590
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Tue Apr 2024 | 5.14 | 4.98 | 5.32 | 4.98 | 0.615 times |
| 22 Mon Apr 2024 | 4.99 | 4.57 | 5.03 | 4.57 | 0.541 times |
| 19 Fri Apr 2024 | 4.54 | 4.67 | 4.72 | 4.40 | 0.937 times |
| 18 Thu Apr 2024 | 4.72 | 5.04 | 5.06 | 4.72 | 0.426 times |
| 17 Wed Apr 2024 | 5.11 | 5.55 | 5.67 | 5.09 | 0.449 times |
| 16 Tue Apr 2024 | 5.56 | 5.27 | 5.76 | 5.18 | 1.024 times |
| 15 Mon Apr 2024 | 5.35 | 5.34 | 5.63 | 5.24 | 0.527 times |
| 12 Fri Apr 2024 | 5.39 | 5.95 | 5.95 | 5.33 | 0.79 times |
| 11 Thu Apr 2024 | 5.92 | 5.58 | 5.94 | 5.48 | 0.92 times |
| 10 Wed Apr 2024 | 5.53 | 5.44 | 5.63 | 5.21 | 0.849 times |
My analysis of stock is bearish for shortterm, and stock might move down till 4.7 or till 4.2. Use a stoploss of 5.19 and if the stock hits stoploss, then it can shoot up till 5.66
Share price targets for Syros Pharmaceuticals (SYRS)
| Target Type | Value |
| Downside Target | 2.47 |
| Downside Target | 4.40 |
| Downside Target | 4.50 |
| Upside Target | 5.15 |
| Upside Target | 5.32 |
| Upside Target | 5.76 |
| Upside Target | 5.95 |
| Upside Target | 6.24 |
| Upside Target | 6.49 |
| Upside Target | 6.63 |
| Upside Target | 7.90 |
| Upside Target | 7.96 |
| Upside Target | 8.05 |
| Upside Target | 8.17 |
Intraday share price targets for Syros Pharmaceuticals (SYRS)
| Target Type | Value |
| Downside Intraday Target | 4.7 |
| Downside Intraday Target | 4.26 |
| Upside Intraday Target | 5.45 |
| Upside Intraday Target | 5.76 |
| Downside Intraday Target | 5.01 |
Weekly technical analysis of Syros Pharmaceuticals (SYRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Tue Apr 2024 | 5.14 | 4.57 | 5.32 | 4.57 | 0.344 times |
| 19 Fri Apr 2024 | 4.54 | 5.34 | 5.76 | 4.40 | 0.506 times |
| 12 Fri Apr 2024 | 5.39 | 4.66 | 5.95 | 4.50 | 1.154 times |
| 05 Fri Apr 2024 | 4.67 | 5.12 | 5.35 | 4.55 | 1.593 times |
| 28 Thu Mar 2024 | 5.35 | 6.25 | 6.49 | 5.15 | 1.883 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Syros Pharmaceuticals (SYRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Tue Apr 2024 | 5.14 | 5.12 | 5.95 | 4.40 | 1.25 times |
| 28 Thu Mar 2024 | 5.35 | 7.31 | 7.90 | 5.15 | 1.055 times |
| 29 Thu Feb 2024 | 7.26 | 7.12 | 7.96 | 6.63 | 0.749 times |
| 31 Wed Jan 2024 | 7.14 | 7.64 | 8.17 | 6.24 | 0.411 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Syros Pharmaceuticals (SYRS)
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Syros Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Syros Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Syros Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Syros Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.27 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Syros Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Syros Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Syros Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Syros Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.27 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.